The World Gathers at the CIIE | Latest Updates from Boyue
Regarding the appearance of GLP-1 at the China International Import Expo (CIIE): the latest generation of semaglutide is now available as an oral tablet. Previously, it was only offered as a once-weekly injection; for those who dislike needles, a daily oral tablet is now an option. Notably, a marketing authorization application for semaglutide has already been submitted in China. Once ingested, the medication—which shares 94% homology with the GLP-1 hormone naturally produced by the body—can cross the blood-brain barrier. It effectively suppresses feelings of hunger by signaling to the brain that the body is already full, thereby reducing "food noise."
Regarding the appearance of GLP-1 at the China International Import Expo (CIIE): the latest generation of semaglutide is now available as an oral tablet. Previously, it was only offered as a once-weekly injection; for those who dislike needles, a daily oral tablet is now an option. Notably, a marketing authorization application for semaglutide has already been submitted in China. Once ingested, the medication—which shares 94% homology with the GLP-1 hormone naturally produced by the body—can cross the blood-brain barrier. It effectively suppresses feelings of hunger by signaling to the brain that the body is already full, thereby reducing "food noise."
